Middle-Aged Adults Taking GLP-1s Could Cut Medical Costs
A fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesA fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
Investors are weighing whether Chevron’s recent steps point to a new growth platform. This deep dive explains what a ...
Intel reached a fresh 52-week high as its foundry strategy gains traction and data-center demand strengthens. The sto...
Oil prices rise and equity futures turn lower as tensions with Iran fresh escalate. Investors brace for higher energy...
ASML, Europe’s largest semiconductor equipment maker, is poised to report second-quarter results as AI-driven demand ...
A prominent SaaS executive warns that AI could erode long-standing moats, while industry data show enduring protectio...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Investors are focusing on the links between battlefield tech and defense earnings as analysts highlight the firearms ...
Budget failure happens more often than you think. This expert guide breaks down the common reasons for budget failure...
MercadoLibre has fallen about a third from its 52-week high, raising questions for investors. This guide breaks down ...
As of March 18, 2026, XRP hovered around $1.50 after a brief push above $1.60. Analysts say the CLARITY Act could det...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...